DIN 02464241 — VEMLIDY 25 MG
VEMLIDY is a tablet of Tenofovir alafenamide marketed by GILEAD SCIENCES CANADA INC. The full Tenofovir alafenamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02464241
- Brand name
- VEMLIDY
- Active ingredient
- Tenofovir alafenamide
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- GILEAD SCIENCES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Nucleotide analogue reverse transcriptase inhibitor (antiviral agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.